Amgen submitted a variation to its Kyprolis marketing authorization application to the European Union, to include a combination with dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. The application is based on results from the phase III head-to-head ENDEAVOR study in which patients with multiple...
A curious piece of paper hangs in a frame outside the director’s office at University of Iowa Holden Comprehensive Cancer Center on the second floor of the General Hospital.
